Donald Trump has pledged to use his executive powers to significantly reduce U.S. prescription drug prices, aiming for cuts between 30% to 80%. He plans to introduce a 'most favoured nation' policy that ensures Americans pay the same price for drugs as the lowest priced country. His announcement triggered a decline in pharmaceutical stocks, as investors feared reduced profits. This move mirrors past efforts during his presidency and builds on Medicare's current price negotiation capabilities under Bidenâs Inflation Reduction Act.
Trump announced he will sign an order to reduce prescription drug prices by up to 80%, pledging to align U.S. costs with the lowest in the world.
The proposed 'most favoured nation' policy aims to ensure that American consumers are no longer the only ones footing the bill for high drug prices.
#prescription-drugs #pharmaceutical-prices #executive-power #trump-administration #healthcare-policy
Collection
[
|
...
]